[1] Martin T,Gooi JH.Molecular mechanisms in coupling of bone formation to resorption.Crit Rev Eukaryot Gene Expr 2009;19:73-88
[2] Matsuo K.Osteoclast-osteoblast communication.Arch Biochem Biophys. 2008; 473:201-209. DOI:10.1016/j.abb.2008.03.027
[3] Phan TC,Xu J.Interaction between osteoblast and osteoclast: impact in bone disease.Histol Histopathol 2004;19:1325-1344
[4] Zhang W,Zhang Y,Liu Y,et al.Thyroid-stimulating hormone maintains bone mass and strength by suppressing osteoclast differentiation.J Biomech 2014;47:1307-1314. DOI:10.1016/j. jbiomech. 2014.02.015
[5] Bassett JH, Williams GR. Role of thyroid hormones in skeletal development and bone maintenance.Endocr Rev (2016) 37:135–87. doi:10.1210/er.2015-1106
[6] Abe E,Marians RC,Yu W,et al.TSH is a negative regulator of skeletal remodeling.Cell 2003; 115:151-162
[7] Bassett JH,Williams AJ,Murphy E,et al.A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.Mol Endocrinol 2008;22:501-512.DOI:10.1210/me.2007-0221
[8] Sampath TK,Simic P,Sendak R,et al.Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.J Bone Miner Res 2007; 22:849-859.DOI:10.1359/jbmr.070302
[9] Hase H,Ando T,Eldeiry L,et al.TNFalpha mediates the skeletal effects of thyroid-stimulating hormone.Proc Natl Acad Sci U S A 2006;103:12849-12854.DOI:10.1073/pnas.0600427103
[10] Gogakos AI,Duncan Bassett JH.Thyroid and bone.Arch Biochem Biophys 2010;503:129-136. DOI:10.1016/j.abb.2010.06.021
[11] Baliram R,Latif R,Berkowitz J,et al.Thyroid-stimulating hormone induces a Wnt-dependent,
feed-forward loop for osteoblastogenesis in embryonic stem cell cultures.Proc Natl Acad Sci U S A 2011;108:16277-16282.DOI:10.1073/pnas.1110286108
[12] Tsai JA,Janson A,Bucht E,et al. Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells. Calcif Tissue Int 2004;74:486-491.DOI:10.1007/s00223-003- 0108-3
[13] Wang, J., Zhang, W., Yu, C., Zhang, X., Zhang, H., Guan, Q., Zhao, J., & Xu, J. (2015). Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation. PloS one, 10(8), e0134986. https://doi.org/10.1371/journal.pone.0134986
[14]Wojcicka,A.,Bassett,J.H.,Williams,G.R.,2012.Mechanisms of action of thyroid hormones in the skeleton.Biochim.Biophys.Acta1830,3979–3986
[15] Bassett JH,van der Spek A,Logan JG,et al.Thyrostimulin Regulates Osteoblastic Bone Formation During Early Skeletal Development.Endocrinology 2015;156:3098-3113.DOI: 10.1210/en.2014-1943
[16] Gogakos A,Logan JG,Waung JA,et al.THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women.Eur J Endocrinol 2014;170:637-644.DOI:10.1530/EJE-13-1009
[17] Allain TJ.Thyroid hormones and bone.J Endocrinol 1993;139:9-18
[18] Lee WY,Oh KW,Rhee EJ,et al.Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women.Arch Med Res 2006;37:511-516. DOI: 10. 1016/j.arcmed.2005.09.009
[19] Segna D,Bauer DC,Feller M,et al.Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.J Intern Med 2018;283:56-72. DOI:10.1111/joim.12688
[20] Ding B,Zhang Y,Li Q,et al.Low Thyroid Stimulating Hormone Levels Are Associated with Low Bone Mineral Density in Femoral Neck in Elderly Women.Arch Med Res 2016;47:310-314. DOI:10.1016/j.arcmed.2016.07.009
[21] Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 2015;313:2055e2065
[22] Svare A,Nilsen TI,Bjøro T,et al.Hyperthyroid levels of TSH correlate with low bone mineral
density: the HUNT 2 study.Eur J Endocrinol 2009;161:779-786.DOI:10.1530/EJE-09-0139
[23] Kim MK,Yun KJ,Kim MH,et al.The effects of thyrotropin-suppressing therapy on bone
Metabolism in patients with well-differentiated thyroid carcinoma.Bone 2015;71:101-105. DOI:10.1016/j.bone.2014.10.009
[24] Leader A,Ayzenfeld RH,Lishner M,et al.Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years.J Clin Endocrinol Metab 2014;99:2665-2673.DOI:10.1210/jc.2013-2474
[25] Mazziotti G,Formenti AM,Frara S,et al.High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma.J Clin Endocrinol Metab 2018;103:956-964.DOI:10.1210/jc.2017-01986
[26] Siderova M,Hristozov K.TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy.Arch Endocrinol Metab 2018;62:221-226.DOI:10.20945/2359-3997000000027
[27] Jeon EJ,Lee KY,Choi NS,et al.Bone morphogenetic protein-2 stimulates Runx2 acetylation.J Biol Chem 2006;281:16502-16511.DOI:10.1074/jbc.M512494200
[28] Matsubara T,Kida K,Yamaguchi A,et al.BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation.J Biol Chem 2008;283:29119-29125. DOI:10.1074/jbc.M 801774200
[29] Sivertsen B,Holliday N,Madsen AN.Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor.Br J Pharmacol 2013;170:1349 -1362. DOI:10.1111/bph.12361
[30] Boutin A,Neumann S.Multiple Transduction Pathways Mediate Thyrotropin Receptor signaling in Preosteoblast-Like Cells.Endocrinology 2016;157:2173-2181. DOI:10.1210/en. 2015-2040
[31] Davies TF.Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.Expert Opin Ther Targets 2015;19:835-847.DOI:10.1517/14728222.2015. 1018181
[32] Baliram R,Latif R,Zaidi M.Expanding the Role of Thyroid-Stimulating Hormone in Skeletal Physiology.Front Endocrinol (Lausanne) 2017;8:252.DOI:10.3389/fendo.2017.00252
[33] Baliram R,Chow A,Huber AK,et al.Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis.Endocrinology 2013;154:4919-4926.DOI:10. 1210/en.2012-2234
[34] Baliram R,Latif R,Morshed SA,et al.T3 Regulates a Human Macrophage-Derived TSH-β Splice Variant: Implications for Human Bone Biology.Endocrinology 2016;157:3658-3667.DOI: 10.1210/en.2015-1974
[35] Vincent BH,Montufar-Solis D,Teng BB,et al.Bone marrow cells produce a novel TSHbeta splice variant that is upregulated in the thyroid following systemic virus infection.Genes Immun 2009;10:18-26.DOI:10.1038/gene.2008.69
[36] Latif R,Ali MR,Ma R,et al.New small molecule agonists to the thyrotropin receptor.Thyroid 2015;25:51-62.DOI:10.1089/thy.2014.0119
[37] Boutin A,Eliseeva E,Gershengorn MC.β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.FASEB J 2014;28:3446-3455.DOI:10.1096/fj.14-251124
[38] Neumann S,Huang W,Titus S,et al.Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.Proc Natl Acad Sci USA 2009;106:12471-12476. DOI:10.1073/pnas.0904506106
[39] Latif R,Realubit RB,Karan C,et al. TSH Receptor Signaling Abrogation by a Novel Small Molecule.Front Endocrinol (Lausanne) 2016;7:130.DOI:10.3389/fendo.2016.00130